As co-director of the renowned Saint Louis University Liver Center, Dr. Di Bisceglie played a key role in identifying and developing treatments for Hepatitis C, ultimately leading to a cure. Dr. Di Bisceglie continues to actively engage in research, while also seeing patients with liver disease, hepatitis B and hepatitis C, and evaluating candidates for liver transplantation. His staff uses the latest innovations in care, such as Fibroscan technology for non-invasive assessment of liver fibrosis in patients.
Dr. Di Bisceglie is a professor in the Department of Internal Medicine at Saint Louis University School of Medicine and Chief of Hepatology in the Division of Gastroenterology and Hepatology. He holds the Bander Chair in Internal Medicine.
Professional memberships include the American Gastroenterological Association and the American Association for the Study of Liver Diseases. Dr. Di Bisceglie is on Twitter (@dibiscam) and tweets about hepatitis and liver disease issues.